Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
AssigneePanaGin Pharmaceuticals Inc.
InventorsDong Huang, Dong Feng Qi
Life of this patent
Estimating the term…
Loading patent…
AssigneePanaGin Pharmaceuticals Inc.
InventorsDong Huang, Dong Feng Qi
Estimating the term…
This invention relates to a group of novel sapogenins, their use in anti-cancer applications, and to a process for their production. More particularly, this invention pertains to a novel group of dammarane sapogenins, PAM-120, PBM-110 and PBM-100 (the dammarance sapogenine structure is specifically clean of any sugar moieties (glycons) at any position and hydroxyl at C-20) and PAN-20 and PAN-30 (the dammarance sapogenin structure has sugar moieties but is free of hydroxyl at C-20), obtained by chemical cleavage of dammarane saponins. The invention also includes a novel application of the said sapogenins for anti-cancer treatment by using them separately or together, and/or jointly with other drugs, as well as to the process of producing these novel sapogenins. Said novel dammarane sapogenins show surprising anti-cancer effect when applied, particularly against multi-drug resistant cancers.
A process of preparing a sapogenin according to the formula:
A process of preparing a sapogenin according to the formula:
A process of preparing a sapogenin according to the formula:
Dependencies are inferred from the claim text.